tirzepatide from china to usa Lilly's Weight-Loss Drug Approved in Amid Race With Novo Newer Weight-Loss Drugs Not Cost-effective

The therapeutic potential of a venomous lizard: The use of glucagon-like peptide-1 analogues in the critically ill

Older age, prior heart failure (HF) and CV events, peripheral artery disease, and kidney complications can identify a subgroup of patients with T2D at high risk of mortality who are likely to achieve the greatest benefit from aggressive management of modifiable risk factors and newer glucose-lowering agents

Support is AI-first with slow human escalation

Vascular and Nerve Effects Since erections depend on strong blood flow and healthy nerve signals, medications that damage blood vessels or nerves can lead to ED